Metagenomi, Inc. Common Stock (MGX)の価格はいくらですか

Metagenomi, Inc. Common Stock (MGX)の価格は$1.21です

Metagenomi, Inc. Common Stock (MGX)の時価総額は何ですか

Metagenomi, Inc. Common Stock (MGX)の時価総額は$45.55Mです

Metagenomi, Inc. Common Stock（MGX）の株価履歴

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

年	パフォーマンス
2026 (TTM)	-2.16%
2025	-48.40%
2024	0.00%

年

パフォーマンス

2026 (TTM)

-2.16%

2025

-48.40%

2024

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$539.14	36.71%	US
Argenx SE ARGX.US	$1.04K	56.86%	NL
CSL Limited CSL.AX	$120.74	-14.98%	AU
Lonza Group AG LONN.SW	$761.87	7.04%	CH
Moderna, Inc. MRNA.US	$130.43	385.07%	US

企業

株価

変化率 1年%

国